New patent for Novo Nordisk drug TRESIBA

Annual Drug Patent Expirations for TRESIBA Tresiba is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are fourteen… The post New patent for Novo Nordisk drug TRESIBA appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog